This week, we will discuss an old dilemma in nephrology. To restrict or supplement the proteins? Premise: advanced CKD and dialysis.
This week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients.
This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?
It is the third rail of Twitter, Maintenance of Certification. But ASN wanted to tackle this head on with a public position and Twitter chat. Take a look at the analytics, storify and transcript.
NephJC has never seen a chat with as many participants or as many tweets,
First tweet was last monday and look at the response! Thanks for getting the word out there!
